Document is current
Any future updates will be listed below
-
Authors
Cao, Jun
Tan, Zhichao
Yang, Enyu
Ji, Qing
Fang, Meiyu
Liu, Jiayong
-
Funding
Funding for this research was provided by:
Tumor Health Standard Diagnosis and Treatment Public Lecture Charity Project (ZLMY 20240425001HZ)
Medical and Health Research Project of Zhejiang Province (2024KY852)
Independent Deployment Project of the Hangzhou Institute of Medicine, Chinese Academy of Sciences— “Platform for Rare Disease Diagnosis and Treatment and Novel Gene Therapy Strategies” (2024ZZBS05-3)
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 27 October 2025
First Online: 26 November 2025
Declarations
:
: The study was approved by the IRBs at Peking University Cancer Hospital (IRB No. 2023YJZ75, 2023-12-05) and Zhejiang Cancer Hospital (IRB No. IRB-2025-209 (IIT), 2025-02-25). Informed patient consent was waived.
: The authors declare no competing interests.
